Search Results (2)

Radiation modeling and kinetics in two different packed-bed reactors filled with TiO₂-coated glass rings are presented. The first reactor was cylindrical, irradiated from one end by a 150 W mercury lamp. It was employed to obtain the values of the intrinsic kinetic parameters of the degradation of the emerging contaminant clofibric acid (CA). The expression to represent the kinetics of the pollutant was derived from a proposed reaction scheme, and it includes explicitly the effect of photon absorption rate on the reaction rate. The second reactor was annular, irradiated internally and externally by 40 UV-LED lamps. The kinetic parameters calculated in the first reactor were directly employed to simulate the performance of the second one, without using any adjustable parameter. The Monte Carlo method was applied to solve the radiation models in both reactors. Good agreement was obtained between simulation results and experimental data under different operating conditions, with a percentage root-mean-square error of 4.6%. The kinetic parameters proved to be independent of the irradiation source, reactor geometry, and catalyst film thickness, and can be readily applied to design real scale devices. Full article

Background: Herpes simplex 1 co-infections in patients with COVID-19 are considered relatively uncommon; some reports on re-activations in patients in intensive-care units were published. The aim of the study was to analyze herpetic re-activations and their clinical manifestations in hospitalized COVID-19 patients, performing HSV-1 PCR on plasma twice a week. Methods: we conducted a prospective, observational, single-center study involving 70 consecutive patients with severe/critical SARS-CoV-2 pneumonia tested for HSV-1 hospitalized at Azienda Ospedaliero-Universitaria of Modena. Results: of these 70 patients, 21 (30.0%) showed detectable viremia and 13 (62%) had clinically relevant manifestations of HSV-1 infection corresponding to 15 events (4 pneumonia, 5 herpes labialis, 3 gingivostomatitis, one encephalitis and two hepatitis). HSV-1 positive patients were more frequently treated with steroids than HSV-1 negative patients (76.2% vs. 49.0%, p = 0.036) and more often underwent mechanical ventilation (IMV) (57.1% vs. 22.4%, p = 0.005). In the unadjusted logistic regression analysis, steroid treatment, IMV, and higher LDH were significantly associated with an increased risk of HSV1 re-activation (odds ratio 3.33, 4.61, and 16.9, respectively). The association with the use of steroids was even stronger after controlling for previous use of both tocilizumab and IMV (OR = 5.13, 95% CI:1.36–19.32, p = 0.016). The effect size was larger when restricting to participants who were treated with high doses of steroids while there was no evidence to support an association with the use of tocilizumab Conclusions: our study shows a high incidence of HSV-1 re-activation both virologically and clinically in patients with SARS-CoV-2 severe pneumonia, especially in those treated with steroids. Full article